| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |